The future of cancer screening after COVID‐19 may be at home | Zendy

Gorin Sherri N. Sheinfeld | Zendy; Jimbo Masahito | Zendy; Heizelman Robert | Zendy; Harmes Kathryn M. | Zendy; Harper Diane M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The future of cancer screening after COVID‐19 may be at home

Author(s) -

Gorin Sherri N. Sheinfeld,

Jimbo Masahito,

Heizelman Robert,

Harmes Kathryn M.,

Harper Diane M.

Publication year - 2021

Publication title -

cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.052

H-Index - 304

eISSN - 1097-0142

pISSN - 0008-543X

DOI - 10.1002/cncr.33274

Subject(s) - medicine , covid-19 , cancer screening , colonoscopy , pandemic , colorectal cancer , breast cancer , cancer , colorectal cancer screening , cervical cancer , telemedicine , coronavirus , intensive care medicine , disease , health care , pathology , infectious disease (medical specialty) , economics , economic growth , outbreak

Lay Summary During the coronavirus disease 2019 (COVID‐19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemedicine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research